Artelo Biosciences Inc

NASDAQ:ARTL  
1.00
-0.03 (-2.94%)
Earnings Announcements

Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results And Provides Business Update

Published: 07/12/2021 14:41 GMT
Artelo Biosciences Inc (ARTL) - Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results and Provides Business Update.
Q3 Loss per Share $0.10.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.08

More details on our Analysts Page.